Hyperkalemia: Difference between revisions
No edit summary |
(Remove refs with incorrect PMIDs (verified against PubMed)) |
||
| (164 intermediate revisions by 35 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Serum potassium >5.0 mEq/L (some define >5.5 mEq/L) | |||
*'''Life-threatening when >6.5 mEq/L''' or with ECG changes | |||
*Most common electrolyte disorder causing [[cardiac arrest]] | |||
*Potassium homeostasis: | |||
**98% intracellular (maintained by Na/K-ATPase) | |||
**Renal excretion is primary mechanism of potassium regulation | |||
===Causes=== | |||
*Decreased excretion (most common mechanism): | |||
**[[Acute kidney injury]] / [[chronic kidney disease]] | |||
**Medications: ACE inhibitors, ARBs, K-sparing diuretics (spironolactone, amiloride), NSAIDs, trimethoprim, heparin | |||
**[[Adrenal insufficiency]] (hypoaldosteronism) | |||
**Type 4 renal tubular acidosis | |||
*Transcellular shift (K moves out of cells): | |||
**Acidosis (metabolic acidosis shifts K extracellularly) | |||
**Insulin deficiency / [[DKA]] | |||
**Tissue destruction: [[rhabdomyolysis]], tumor lysis, hemolysis, burns | |||
**Succinylcholine, beta-blockers, digitalis toxicity | |||
**Hyperkalemic periodic paralysis | |||
*Increased intake: excessive supplementation, salt substitutes (KCl) | |||
*Pseudohyperkalemia: hemolyzed sample, prolonged tourniquet, thrombocytosis, leukocytosis | |||
**Always repeat level if unexpected | |||
==Clinical Features== | |||
*Often asymptomatic until severe | |||
*Muscle weakness, fatigue, paresthesias | |||
*Ascending paralysis (may mimic [[Guillain-Barre]]) | |||
*'''Cardiac dysrhythmias''' (most dangerous manifestation) | |||
*Nausea, vomiting, diarrhea | |||
===ECG Changes (Progressive)=== | |||
*Peaked T waves (earliest change, typically >5.5 mEq/L)<ref>Montague BT, et al. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008;3(2):324-330. PMID 18235147</ref> | |||
*Prolonged PR interval | |||
*Widened QRS | |||
== | *Loss of P waves | ||
*Sine wave pattern (pre-arrest) | |||
*Ventricular fibrillation / asystole | |||
*'''ECG changes do NOT reliably correlate with K level''' — some patients arrest without warning | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Pseudohyperkalemia (hemolyzed specimen) | |||
*[[Acute kidney injury]] / [[chronic kidney disease]] | |||
*[[DKA]] | |||
*[[Rhabdomyolysis]] | |||
* | |||
*Rhabdomyolysis | |||
*Tumor lysis syndrome | *Tumor lysis syndrome | ||
* | *[[Adrenal insufficiency]] | ||
*Medication effect | |||
* | |||
* | ==Evaluation== | ||
*'''Stat ECG''' (most urgent — look for peaked T's, widened QRS) | |||
*BMP: potassium level, creatinine (renal function), glucose, bicarbonate | |||
*Repeat K level if unexpected (rule out pseudohyperkalemia) | |||
*VBG/ABG (acidosis evaluation) | |||
*Digoxin level if on digoxin (hyperkalemia potentiates digitalis toxicity) | |||
*Urinalysis (myoglobinuria if rhabdomyolysis) | |||
*Consider: CK, uric acid, phosphorus (tumor lysis), cortisol (adrenal insufficiency) | |||
==Management== | |||
===Step 1: Cardiac Membrane Stabilization=== | |||
*Calcium (does NOT lower K; protects myocardium from arrhythmia): | |||
**Calcium gluconate 10%: 10-20 mL IV over 2-3 minutes (preferred; less tissue necrosis if extravasates) | |||
**Calcium chloride 10%: 5-10 mL IV (via central line preferred; 3x more elemental calcium) | |||
**Onset: 1-3 minutes; duration 30-60 minutes; may repeat in 5-10 min if ECG unchanged | |||
**'''Give immediately if ECG changes present or K >6.5''' | |||
*Caution in [[digoxin toxicity]]: calcium may worsen toxicity → use cautiously or consider digibind first | |||
== | ===Step 2: Shift Potassium Intracellularly=== | ||
*Insulin + Glucose (most reliable):<ref>Mahoney BA, et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev. 2005;(2):CD003235. PMID 15846652</ref> | |||
**Regular insulin 10 units IV + D50W 25g (50 mL) IV | |||
**Onset: 15-30 min; duration 4-6 hours; lowers K by 0.5-1.2 mEq/L | |||
**Monitor glucose q30min x 4h (hypoglycemia occurs in up to 20%) | |||
**Give D50 before or simultaneously with insulin | |||
*Albuterol (nebulized): | |||
**10-20 mg nebulized (4-8x standard asthma dose) | |||
**Onset: 15-30 min; lowers K by 0.5-1.5 mEq/L | |||
**Additive with insulin; 40% of patients are non-responders | |||
*Sodium bicarbonate: | |||
**50-100 mEq IV over 5-10 minutes | |||
**Minimal effect as monotherapy; useful in setting of severe metabolic acidosis | |||
**'''Do NOT rely on bicarb alone''' to lower potassium | |||
===Step 3: Remove Potassium from Body=== | |||
*Loop diuretics (furosemide 40-80 mg IV): if adequate renal function | |||
*Sodium polystyrene sulfonate (Kayexalate) 15-30g PO: | |||
**Delayed onset (hours); controversial efficacy; risk of bowel necrosis | |||
**Not recommended as acute treatment | |||
*Patiromer (Veltassa) or sodium zirconium cyclosilicate (Lokelma): | |||
**Newer potassium binders; better tolerated than Kayexalate | |||
**Lokelma 10g PO may lower K within 1 hour | |||
*Hemodialysis (most effective method of K removal): | |||
**Indicated for: refractory hyperkalemia, severe renal failure, K >7 despite medical therapy | |||
===Cardiac Arrest from Hyperkalemia=== | |||
*Standard ACLS + calcium 10-20 mL IV push | |||
*Insulin + glucose + bicarb + albuterol simultaneously | |||
*Avoid succinylcholine for intubation | |||
*Consider emergent dialysis | |||
==Disposition== | |||
*Admit if K >6.0, ECG changes, renal failure, or ongoing cause | |||
*ICU if severe (>7.0), ECG changes, or refractory to treatment | |||
*Continuous telemetry for all admitted patients | |||
*Consider discharge if mild hyperkalemia (5.0-5.5), known chronic cause, normal ECG, correctable precipitant | |||
==See Also== | |||
*[[Hypokalemia]] | |||
*[[Acute kidney injury]] | |||
*[[Diabetic ketoacidosis]] | |||
*[[Rhabdomyolysis]] | |||
*[[Cardiac arrest]] | |||
*[[Digoxin toxicity]] | |||
==References== | |||
*Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. ''N Engl J Med''. 2004;351(6):585-592. PMID 15295051 | |||
*Weisberg LS. Management of severe hyperkalemia. ''Crit Care Med''. 2008;36(12):3246-3251. PMID 18936701 | |||
*Montford JR, Linas S. How dangerous is hyperkalemia? ''J Am Soc Nephrol''. 2017;28(11):3155-3165. PMID 28778861 | |||
*Long B, et al. An emergency medicine approach to hyperkalemia. ''Am J Emerg Med''. 2018;36(5):918-921. PMID 29548654 | |||
[[Category: | [[Category:Renal]] | ||
[[Category:Critical Care]] | |||
Latest revision as of 10:25, 22 March 2026
Background
- Serum potassium >5.0 mEq/L (some define >5.5 mEq/L)
- Life-threatening when >6.5 mEq/L or with ECG changes
- Most common electrolyte disorder causing cardiac arrest
- Potassium homeostasis:
- 98% intracellular (maintained by Na/K-ATPase)
- Renal excretion is primary mechanism of potassium regulation
Causes
- Decreased excretion (most common mechanism):
- Acute kidney injury / chronic kidney disease
- Medications: ACE inhibitors, ARBs, K-sparing diuretics (spironolactone, amiloride), NSAIDs, trimethoprim, heparin
- Adrenal insufficiency (hypoaldosteronism)
- Type 4 renal tubular acidosis
- Transcellular shift (K moves out of cells):
- Acidosis (metabolic acidosis shifts K extracellularly)
- Insulin deficiency / DKA
- Tissue destruction: rhabdomyolysis, tumor lysis, hemolysis, burns
- Succinylcholine, beta-blockers, digitalis toxicity
- Hyperkalemic periodic paralysis
- Increased intake: excessive supplementation, salt substitutes (KCl)
- Pseudohyperkalemia: hemolyzed sample, prolonged tourniquet, thrombocytosis, leukocytosis
- Always repeat level if unexpected
Clinical Features
- Often asymptomatic until severe
- Muscle weakness, fatigue, paresthesias
- Ascending paralysis (may mimic Guillain-Barre)
- Cardiac dysrhythmias (most dangerous manifestation)
- Nausea, vomiting, diarrhea
ECG Changes (Progressive)
- Peaked T waves (earliest change, typically >5.5 mEq/L)[1]
- Prolonged PR interval
- Widened QRS
- Loss of P waves
- Sine wave pattern (pre-arrest)
- Ventricular fibrillation / asystole
- ECG changes do NOT reliably correlate with K level — some patients arrest without warning
Differential Diagnosis
- Pseudohyperkalemia (hemolyzed specimen)
- Acute kidney injury / chronic kidney disease
- DKA
- Rhabdomyolysis
- Tumor lysis syndrome
- Adrenal insufficiency
- Medication effect
Evaluation
- Stat ECG (most urgent — look for peaked T's, widened QRS)
- BMP: potassium level, creatinine (renal function), glucose, bicarbonate
- Repeat K level if unexpected (rule out pseudohyperkalemia)
- VBG/ABG (acidosis evaluation)
- Digoxin level if on digoxin (hyperkalemia potentiates digitalis toxicity)
- Urinalysis (myoglobinuria if rhabdomyolysis)
- Consider: CK, uric acid, phosphorus (tumor lysis), cortisol (adrenal insufficiency)
Management
Step 1: Cardiac Membrane Stabilization
- Calcium (does NOT lower K; protects myocardium from arrhythmia):
- Calcium gluconate 10%: 10-20 mL IV over 2-3 minutes (preferred; less tissue necrosis if extravasates)
- Calcium chloride 10%: 5-10 mL IV (via central line preferred; 3x more elemental calcium)
- Onset: 1-3 minutes; duration 30-60 minutes; may repeat in 5-10 min if ECG unchanged
- Give immediately if ECG changes present or K >6.5
- Caution in digoxin toxicity: calcium may worsen toxicity → use cautiously or consider digibind first
Step 2: Shift Potassium Intracellularly
- Insulin + Glucose (most reliable):[2]
- Regular insulin 10 units IV + D50W 25g (50 mL) IV
- Onset: 15-30 min; duration 4-6 hours; lowers K by 0.5-1.2 mEq/L
- Monitor glucose q30min x 4h (hypoglycemia occurs in up to 20%)
- Give D50 before or simultaneously with insulin
- Albuterol (nebulized):
- 10-20 mg nebulized (4-8x standard asthma dose)
- Onset: 15-30 min; lowers K by 0.5-1.5 mEq/L
- Additive with insulin; 40% of patients are non-responders
- Sodium bicarbonate:
- 50-100 mEq IV over 5-10 minutes
- Minimal effect as monotherapy; useful in setting of severe metabolic acidosis
- Do NOT rely on bicarb alone to lower potassium
Step 3: Remove Potassium from Body
- Loop diuretics (furosemide 40-80 mg IV): if adequate renal function
- Sodium polystyrene sulfonate (Kayexalate) 15-30g PO:
- Delayed onset (hours); controversial efficacy; risk of bowel necrosis
- Not recommended as acute treatment
- Patiromer (Veltassa) or sodium zirconium cyclosilicate (Lokelma):
- Newer potassium binders; better tolerated than Kayexalate
- Lokelma 10g PO may lower K within 1 hour
- Hemodialysis (most effective method of K removal):
- Indicated for: refractory hyperkalemia, severe renal failure, K >7 despite medical therapy
Cardiac Arrest from Hyperkalemia
- Standard ACLS + calcium 10-20 mL IV push
- Insulin + glucose + bicarb + albuterol simultaneously
- Avoid succinylcholine for intubation
- Consider emergent dialysis
Disposition
- Admit if K >6.0, ECG changes, renal failure, or ongoing cause
- ICU if severe (>7.0), ECG changes, or refractory to treatment
- Continuous telemetry for all admitted patients
- Consider discharge if mild hyperkalemia (5.0-5.5), known chronic cause, normal ECG, correctable precipitant
See Also
- Hypokalemia
- Acute kidney injury
- Diabetic ketoacidosis
- Rhabdomyolysis
- Cardiac arrest
- Digoxin toxicity
References
- Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. PMID 15295051
- Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008;36(12):3246-3251. PMID 18936701
- Montford JR, Linas S. How dangerous is hyperkalemia? J Am Soc Nephrol. 2017;28(11):3155-3165. PMID 28778861
- Long B, et al. An emergency medicine approach to hyperkalemia. Am J Emerg Med. 2018;36(5):918-921. PMID 29548654
